Current advances in the inhibition of the auto-regulatory interaction between the p53 tumour suppressor protein and MDM2 protein

Author： Dart Dafydd A Mansoor Maqsood S Loadman Paul M Picksley Steven M

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.11, Iss.12, 2001-12, pp. : 1825-1835

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small Molecule Protein-Protein Inhibitors for the p53-MDM2 Interaction

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 10, 2007-05 ,pp. : 952-960

Bentham Science Publishers

Access to resources Recommend Favorite

Cellular Distribution of Tumour Suppressor Protein p53 and High-risk Human Papillomavirus (HPV)-18 E6 Fusion Protein in Wild-type p53 Cell Lines

By Sun L Zhang G Li Z Lei T Huang C Song T Si L

The Journal of International Medical Research, Vol. 36, Iss. 5, 2008-09 ,pp. : 1015-1021

Field House Publishing

Access to resources Recommend Favorite

Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?

Current Medicinal Chemistry, Vol. 21, Iss. 5, 2014-02 ,pp. : 553-574

Bentham Science Publishers

Access to resources Recommend Favorite

Patented small molecule inhibitors of p53–MDM2 interaction

By Deng Jinxia Dayam Raveendra Neamati Nouri

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 2, 2006-02 ,pp. : 165-188

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule Inhibitors of p53/MDM2 Interaction

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 2, 2005-04 ,pp. : 159-165

Bentham Science Publishers

Access to resources Recommend Favorite